Indications
Active immunisation of pigs over the age of three weeks against porcine circovirus type 2 (PCV2) to reduce viral load in blood and lymphoid tissues, and the lesions in lymphoid tissues associated with PCV2 infection, as well as to reduce clinical signs - including loss of daily weight gain, and mortality associated with post-weaning multisystemic wasting syndrome.
Composition
- Active substance
- porcine circovirus recombinant virus (CPCV) 1-2, inactivated
- International name (INN)
- adjuvanted inactivated vaccine against porcine circovirus type 2 in piglets
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Suvaxyn PCV
- Active substance
- porcine circovirus recombinant virus (CPCV) 1-2, inactivated
- Group
- Veterinary medicines